Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Apremilast, sold under the brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. The drug acts as a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4). It is taken by mouth.
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Apremilast.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Apremilast shows recurring relationship patterns in the source. For example, Apremilast → Accord Healthcare, American, Amgen's, Apremilast Accord, April, Behcet's, Canada, Committee, European Medicines Agency, European Union, Generic, Human Use, In April, In February, January, Medicinal Products, Otezla, The Another extracted example is Apremilast → IFN-γ IL-2, IL-10, IL-12, IL-23, In, It, PDE4, The, TNF-α. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
treatment otezla psoriasis arthritis enzyme psoriatic others us indicated european use pde4 hours mouth adults plaque associated union drug celgene
TTTA extracted 116 structured relationships around Apremilast. Examples in this analysis include Apremilast → 3D model (JSmol) → Interactive image and Apremilast → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Apremilast | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Apremilast | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Apremilast | ATC code | L04AA32 (WHO) | 1.00 | infobox |
| Apremilast | Bioavailability | 73%; Tmax = ~2.5 hours | 1.00 | infobox |
| Apremilast | CAS Number | 608141-41-9 | 1.00 | infobox |
| Apremilast | ChEBI | CHEBI:78540 | 1.00 | infobox |
| Apremilast | ChEMBL | ChEMBL514800 | 1.00 | infobox |
| Apremilast | ChemSpider | 9736448 | 1.00 | infobox |
| Apremilast | CompTox Dashboard (EPA) | DTXSID30976289 | 1.00 | infobox |
| Apremilast | DrugBank | DB05676 | 1.00 | infobox |
| Apremilast | ECHA InfoCard | 100.234.786 | 1.00 | infobox |
| Apremilast | Elimination half-life | 6–9 hours | 1.00 | infobox |
| Apremilast | Excretion | Urine (58%), faeces (39%) | 1.00 | infobox |
| Apremilast | Formula | C22H24N2O7S | 1.00 | infobox |
| Apremilast | KEGG | D08860 | 1.00 | infobox |
| Apremilast | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Apremilast | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Apremilast | Legal status | US: ℞-only | 1.00 | infobox |
| Apremilast | Legal status | EU: Rx-only | 1.00 | infobox |
| Apremilast | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Apremilast | License data | US DailyMed: Apremilast | 1.00 | infobox |
| Apremilast | MedlinePlus | a614022 | 1.00 | infobox |
| Apremilast | Metabolism | Liver (CYP3A4, with minor contributions from CYP2A6, CYP1A2) | 1.00 | infobox |
| Apremilast | Metabolites | O-desmethylapremilast glucuronide (and others) | 1.00 | infobox |
| Apremilast | Molar mass | 460.50 g·mol−1 | 1.00 | infobox |
| Apremilast | Other names | CC-10004 | 1.00 | infobox |
| Apremilast | Pregnancy category | AU: B3 | 1.00 | infobox |
| Apremilast | Pronunciation | /əˈprɛmɪlæst/ ə-PREM-i-last | 1.00 | infobox |
| Apremilast | Protein binding | c. 68% | 1.00 | infobox |
| Apremilast | PubChem CID | 11561674 | 1.00 | infobox |
The concept neighborhoods around Apremilast bring nearby vocabulary together. In this analysis, examples include Arthritis, Treatment and European. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Apremilast, one of the stronger structural bridges in this analysis connects Apremilast with Pharmacology. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Apremilast to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Apremilast · EN edition · Analysis: TopicsToTalkAbout